share_log

Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6

Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6

Roth MKM 以买入评级开始对Tenax Therapeutics进行报道,宣布目标股价为6美元
Benzinga ·  2023/03/07 07:09

Roth MKM analyst Jonathan Aschoff initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Buy rating and announces Price Target of $6.

Roth MKM分析师乔纳森·阿肖夫以买入评级开始对Tenax Therapeutics(纳斯达克股票代码:TENX)进行报道,并宣布目标价为6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发